We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
2019 Clinical Practice Guidelines for Type 2 Diabetes Mellitus in Korea.
- Authors
Mee Kyoung Kim; Seung-Hyun Ko; Bo-Yeon Kim; Eun Seok Kang; Junghyun Noh; Soo-Kyung Kim; Seok-O Park; Kyu Yeon Hur; Suk Chon; Min Kyong Moon; Nan-Hee Kim; Sang Yong Kim; Sang Youl Rhee; Kang-Woo Lee; Jae Hyeon Kim; Eun-Jung Rhee; SungWan Chun; Sung Hoon Yu; Dae Jung Kim; Hyuk-Sang Kwon
- Abstract
The Committee of Clinical Practice Guidelines of the Korean Diabetes Association revised and updated the 6th Clinical Practice Guidelines in 2019. Targets of glycemic, blood pressure, and lipid control in type 2 diabetes mellitus (T2DM) were updated. The obese and overweight population is increasing steadily in Korea, and half of the Koreans with diabetes are obese. Evidence-based recommendations for weight-loss therapy for obesity management as treatment for hyperglycemia in T2DM were provided. In addition, evidence from large clinical studies assessing cardiovascular outcomes following the use of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide 1 receptor agonists in patients with T2DM were incorporated into the recommendations.
- Subjects
SOUTH Korea; TYPE 2 diabetes; GLUCAGON-like peptide 1; PEPTIDE receptors
- Publication
Diabetes & Metabolism Journal, 2019, Vol 43, Issue 4, p398
- ISSN
2233-6079
- Publication type
Article
- DOI
10.4093/dmj.2019.0137